Glycopyrronium bromide 12.5ug clinical trials

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma

This study is looking at a new asthma medicine, glycopyrronium, for children aged 6 to 11. Researchers want to see how well different doses work, how safe they are, and if they can help children breathe easier. This information will help develop a new combination asthma treatment.